FFA
SANA icon

Farther Finance Advisors’s Sana Biotechnology SANA Stock Holding History

Farther Finance Advisors’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.69K Hold
2,490
– – ﹤0.01% 4516
2026
Q1 		$7.59K Sell
2,490
-1
-0% -$4 ﹤0.01% 4284
2025
Q4 		$10.1K Buy
2,491
+491
+25% +$2.2K ﹤0.01% 3897
2025
Q3 		$7.1K Sell
2,000
-3,064
-61% -$11.1K ﹤0.01% 3602
2025
Q2 		$13.8K Sell
5,064
-7,291
-59% -$15K ﹤0.01% 2898
2025
Q1 		$18.5K Buy
+12,355
New +$34.5K ﹤0.01% 2423
2024
Q4 		– Sell
-14
Closed -$58 – 4129
2024
Q3 		$58 Hold
14
– – ﹤0.01% 3854
2024
Q2 		$77 Hold
14
– – ﹤0.01% 3631
2024
Q1 		$142 Hold
14
– – ﹤0.01% 3326
2023
Q4 		$57 Buy
+14
New +$52 ﹤0.01% 3362

Other funds holding SANA

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PAM
Prodigy Asset Management Omaha, Nebraska $332M AUM 10.57% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
BCA
Bay Colony Advisors Concord, Massachusetts $903M AUM 33.67% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Farther Finance Advisors's SANA Position: Q2 2026 in Review

Farther Finance Advisors held its Sana Biotechnology (SANA) position steady in Q2 2026 at 2,490 shares worth $8.69K. The position accounts for ﹤0.01% of the portfolio, ranked #4516.

Farther Finance Advisors first reported a position in SANA in Q4 2023 and has held it in 10 quarters since. The position peaked at $18.5K in Q1 2025. 8 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Farther Finance Advisors held 2,490 shares of Sana Biotechnology worth $8.69K as of Q2 2026.
  • Farther Finance Advisors left its Sana Biotechnology share count unchanged in Q2 2026.
  • Sana Biotechnology made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4516 holding.
  • Farther Finance Advisors first reported a position in Sana Biotechnology in Q4 2023 and has held it in 10 quarters since.
  • Farther Finance Advisors's Sana Biotechnology position peaked at $18.5K in Q1 2025.
  • 8 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.